Bosch has soared 17% to Rs 11,500, also its record high on the BSE, on buzz that the parent company may hike stake in the company.
The stock has opened at Rs 9,850 and seen over two-fold jump in trading volumes. A combined 74,000 shares have already changed hands on the counter against an average less than 10,000 shares that were traded daily in past two weeks on the BSE and NSE.
Shares of multinational company (MNC) engaged in auto parts and equipment business has outperformed the market by gaining 30% in past six trading sessions against 2.2% rise in benchmark S&P BSE Sensex.
Robert Bosch Gmbh, the Germany-based parent company, held 71% stake in Bosch as on September 30, 2013.
Open offers from MNCs like Hindustan Unilever, GlaxoSmithKline Consumer and GlaxoSmithKline Pharmaceuticals in the last one year make investors optimistic.
Earlier this month, GlaxoSmithKline Plc (GSK) had made an open offer to increase its holding in GlaxoSmithKline Pharmaceuticals to up to 75% from 50.67% at offer price of Rs 3,100 per share.
In July this year, HUL hiked its stake by 14.8% to 67.25% , while in November 2012, GlaxoSmithKline Consumer announced an open offer to increase its stake from 43.2% to 72.46%, at Rs 3,900 per share.
The stock has opened at Rs 9,850 and seen over two-fold jump in trading volumes. A combined 74,000 shares have already changed hands on the counter against an average less than 10,000 shares that were traded daily in past two weeks on the BSE and NSE.
Shares of multinational company (MNC) engaged in auto parts and equipment business has outperformed the market by gaining 30% in past six trading sessions against 2.2% rise in benchmark S&P BSE Sensex.
Robert Bosch Gmbh, the Germany-based parent company, held 71% stake in Bosch as on September 30, 2013.
Open offers from MNCs like Hindustan Unilever, GlaxoSmithKline Consumer and GlaxoSmithKline Pharmaceuticals in the last one year make investors optimistic.
Earlier this month, GlaxoSmithKline Plc (GSK) had made an open offer to increase its holding in GlaxoSmithKline Pharmaceuticals to up to 75% from 50.67% at offer price of Rs 3,100 per share.
In July this year, HUL hiked its stake by 14.8% to 67.25% , while in November 2012, GlaxoSmithKline Consumer announced an open offer to increase its stake from 43.2% to 72.46%, at Rs 3,900 per share.
